Knowledge, Support & Connection
for the Migraine Community
For patients, caregivers, and families. Sourced from clinical guidelines and peer-reviewed research.
Trusted Migraine Information for Patients & Families
Explore Our Resources
Understanding Migraine
Types, triggers, phases, and how migraine affects the brain
Explore Guide
Living with Migraine
Trigger management, lifestyle changes, and daily strategies
Explore Guide
Caregiving & Support
How to support someone with migraine
Explore Guide
Migraine Prevention
Lifestyle strategies, preventive medications, and trigger avoidance
Explore Guide
Treatment Options
CGRP therapies, preventive medications, and acute treatments
Explore Guide
Research & News
Latest developments in treatment and research
Latest Updates
Patient Stories
Real perspectives from patients and families
Read StoriesStay Informed
Get weekly migraine treatment updates, prevention strategies, and community stories: no spam, unsubscribe anytime
We respect your privacy. Unsubscribe anytime.
Recent Articles
- Beyond CGRP: The PACAP Pathway Offers New Hope for Treatment-Resistant Migraine
For the 30-40% of people whose migraine doesn’t improve with CGRP drugs, researchers have found a new target: PACAP (pituitary adenylate cyclase-activating polypeptide). The Phase… - FDA Updates Safety Labels on All CGRP Migraine Drugs: What You Should Know
Between August 2024 and 2025, the FDA required updated safety labels on all CGRP-targeting migraine medications, adding warnings for new or worsening high blood pressure… - FDA Approves First CGRP Migraine Preventive for Children Ages 6 and Up
In August 2025, the FDA approved Ajovy (fremanezumab) as the first anti-CGRP preventive treatment for episodic migraine in children and adolescents ages 6 to 17… - Qulipta Beats Topiramate Head-to-Head for Migraine Prevention, With Fewer Side Effects
The TEMPLE trial, the first Phase 3 head-to-head study comparing a CGRP-based preventive to a traditional oral migraine preventive, found that Qulipta (atogepant) outperformed topiramate…